Literature DB >> 11511307

Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.

C Kennedy1, J ter Huurne, M Berkhout, N Gruis, M Bastiaens, W Bergman, R Willemze, J N Bavinck.   

Abstract

Individuals carrying melanocortin 1 receptor gene variants have an increased risk for the development of cutaneous melanoma. Melanocortin 1 receptor gene variants are also associated with other risk factors for melanoma such as fair skin and red hair. We evaluated the relationship of melanocortin 1 receptor gene variants, fair skin, red hair and the development of melanoma in 123 patients with cutaneous melanoma and 385 control subjects. To analyze the association between melanocortin 1 receptor gene variants and skin type or hair color we also made use of 453 patients with nonmelanoma skin cancer. We analyzed the coding sequence of the melanocortin 1 receptor gene region by single-stranded conformation polymorphism analysis, followed by DNA sequence analysis. Risk of melanoma dependent on the various melanocortin 1 receptor variant alleles was estimated by exposure odds ratios. The analyses of all different melanocortin 1 receptor gene variants combined, showed that the presence of melanocortin 1 receptor gene variants amounted to a higher melanoma risk, which, in stratified analyses, was independent of skin type and hair color. The odds ratios after adjusting for skin type were 3.6 (95% CI 1.7-7.2) for two variants and 2.7 (95% CI 1.5-5.1) for one variant, respectively. Compound heterozygotes and homozygotes for the Val60Leu, Val92Met, Arg142His, Arg151Cys, Arg160Trp, Arg163Gln, and His260Pro variants had odds ratios of about 4 to develop melanoma, whereas heterozygotes for these variants had half the risk. The presence of the melanocortin 1 receptor gene variant Asp84Glu appeared to impose the highest risk for cutaneous melanoma with odds ratios of 16.1 (95% CI 2.3-139.0) and 8.1 (95% CI 1.2-55.9) in compound heterozygotes and heterozygotes, respectively. The broad confidence intervals, when the different variants were analyzed separately, however, do not allow drawing definite conclusions about the magnitude of these risks. Of the more frequently occurring melanocortin 1 receptor variant alleles the Asp84Glu, Arg142His, Arg151Cys, Arg160Trp, His260Pro, and Asp294His variants were strongly associated with both fair skin and red hair. The Val60Leu, Val92Met, and Arg163Gln variant alleles, however, were only weakly or not associated with fair skin type and/or red hair, which further illustrates the finding that skin type, hair color, and melanoma are independent outcomes of the presence of melanocortin 1 receptor gene variants. We conclude that numerous melanocortin 1 receptor variants predispose to cutaneous melanoma and that possibly the Asp84Glu variant confers the highest risk. This predisposition is largely independent of skin type and hair color.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511307     DOI: 10.1046/j.0022-202x.2001.01421.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  115 in total

1.  Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.

Authors:  P A van der Velden; L A Sandkuijl; W Bergman; S Pavel; L van Mourik; R R Frants; N A Gruis
Journal:  Am J Hum Genet       Date:  2001-08-07       Impact factor: 11.025

Review 2.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.

Authors:  Jiali Han; Abrar A Qureshi; Hongmei Nan; Jiangwen Zhang; Yiqing Song; Qun Guo; David J Hunter
Journal:  Cancer Res       Date:  2011-01-26       Impact factor: 12.701

4.  Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?

Authors:  Peter A Kanetsky; Saarene Panossian; David E Elder; DuPont Guerry; Michael E Ming; Lynn Schuchter; Timothy R Rebbeck
Journal:  Cancer       Date:  2010-05-15       Impact factor: 6.860

Review 5.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

Review 6.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

7.  On combining family and case-control studies.

Authors:  Ruth M Pfeiffer; David Pee; Maria T Landi
Journal:  Genet Epidemiol       Date:  2008-11       Impact factor: 2.135

8.  Melanoma molecular subtypes: unifying and paradoxical results.

Authors:  Nancy E Thomas; Peter A Kanetsky; Colin B Begg; Kathleen Conway; Marianne Berwick
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

Review 9.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

10.  Skin pigmentation, biogeographical ancestry and admixture mapping.

Authors:  Mark D Shriver; Esteban J Parra; Sonia Dios; Carolina Bonilla; Heather Norton; Celina Jovel; Carrie Pfaff; Cecily Jones; Aisha Massac; Neil Cameron; Archie Baron; Tabitha Jackson; George Argyropoulos; Li Jin; Clive J Hoggart; Paul M McKeigue; Rick A Kittles
Journal:  Hum Genet       Date:  2003-02-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.